Effects of acute and two week intake of salbutamol on anaerobic power and capacity during repeated bouts of exercise in elite cyclists
M. Hostrup, A. Kalsen, J. Bangsbo, V. Backer (Copenhagen, Denmark)
Source: Annual Congress 2012 - Exercise capacity: from elite athletes to severe impairment
Session: Exercise capacity: from elite athletes to severe impairment
Session type: Thematic Poster Session
Number: 854
Disease area: Airway diseases
Abstract Rationale: Salbutamol, was of 2010 relieved from WADA‘s prohibited list needing a strict diagnosis of asthma, and can now be used more freely among athletes. Some studies have showed enhancing effects of oral salbutamol on anaerobic power in recreational men and women. However, no studies have investigated this in elite athletes. The aim of this study was to examine whether oral salbutamol, taken acutely and over a period of two weeks, increases anaerobic power during repeated Wingate tests in elite cyclists. Method: We enrolled 20 non-asthmatic elite cyclists (M), aged 25.8±4.4yrs, VO2max 68.6±5.8 ml/min/kg, and a training volume of 14.4±3.6 h/wk. The cyclists were randomized into either oral salbutamol 8 mg (SAL) or placebo (PLA) in a double-blinded parallel study. The protocol consisted of three 30-s Wingate tests separated by two minutes of recovery. The intervention consisted of study visits at baseline, after acute ingestion and after two week ingestion taken two-three hours prior to the cyclists‘ regular training. Results: Two week ingestion of salbutamol significantly increased peak power in the first (p<0.05) and second (p<0.001) Wingate, 894±48W and 885±51W versus 861±53W and 848±54W at baseline. Furthermore, the SAL-group had a significant higher mean peak power over 5s at both the first (p<0.05) and the second (p<0.05) Wingate, with 861±42W and 829±56W versus 809±58W and 795±59W at baseline. Acute ingestion of salbutamol didn‘t increase any parameter in the SAL-group. No differences were found in the PLA-group. Conclusions: Two week daily intake of salbutamol taken prior to training improves anaerobic power in elite cyclists.
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Hostrup, A. Kalsen, J. Bangsbo, V. Backer (Copenhagen, Denmark). Effects of acute and two week intake of salbutamol on anaerobic power and capacity during repeated bouts of exercise in elite cyclists. Eur Respir J 2012; 40: Suppl. 56, 854
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Short-term ingestion of salbutamol increases isometric muscle power in endurance athletes Source: Annual Congress 2012 - Exercise capacity: from elite athletes to severe impairment Year: 2012
Effect of endurance and maximal exercise on reticulocytes in athletes Source: Eur Respir J 2004; 24: Suppl. 48, 326s Year: 2004
Effects of aerobic and strength training on symptoms and exercise capacity of IPF patients Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012
Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD Source: Eur Respir J , 49 (4) 1601348; DOI: 10.1183/13993003.01348-2016 Year: 2017
Effect of sub-maximal exercise on breathing energy expenditure Source: Annual Congress 2008 - Exercise: system responses Year: 2008
Eucapnic voluntary hyperpnea versus exercise challenge in identifying exercise induced bronchoconstriction in elite athletes Source: Eur Respir J 2005; 26: Suppl. 49, 371s Year: 2005
Inhalation of terbutaline increases anaerobic performance and muscle strength in well-trained endurance athletes Source: Annual Congress 2013 –Clinical exercise physiology Year: 2013
Effects of helium-hyperoxia on maximal and submaximal exercise responses in hypoxaemic males with COPD Source: Annual Congress 2008 - Exercise: system responses Year: 2008
Effects of hypoxemia correction by acute O2 supply on endurance exercise testing in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005
Does ‘live high-train low’ hypoxic training really improves endurance capacity of long distance runners? Source: International Congress 2017 – Respiratory and exercise physiology Year: 2017
Effects of O2 supplementation during exercise training in COPD Source: ERS Course 2017 Year: 2017
Advantages of endurance treadmill walking compared to cycling to assess bronchodilator therapy Source: Annual Congress 2010 - Research development in exercise and gas exchange Year: 2010
Combined inhalation of beta2-agonists improves supramaximal exercise performance and muscle strength in elite swimmers Source: Annual Congress 2013 –Clinical exercise physiology Year: 2013
Effects of aerobic training on perception of exercise induced bronchoconstriction in asthmatic boys Source: Eur Respir J 2006; 28: Suppl. 50, 476s Year: 2006
Effect of Heliox and hyperoxia on exercise endurance capacity of patients with severe emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 357s Year: 2001
Acute effect of/on exercise endurance time in COPD subjects with different degree of severity and different impairment in exercise tolerance Source: Annual Congress 2009 - Oxygen, end-of-life and care for chronic respiratory patients Year: 2009
The effect of 1-week treatment with permitted inhalation or prohibited oral doses of salbutamol on repeated sprint ability in healthy well-trained men and women Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions Year: 2018
Lung function, aerobic capacity and exercise induced asthma in adolescent elite swimmers with light to severe airway symptoms Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010
Isocapnic hyperpnoea training in wheelchair racing athletes Source: Eur Respir J 2005; 26: Suppl. 49, 108s Year: 2005
Influence of long-acting β2-agonist and sustained-release theophylline on maximal exercise capacity and endurance time in asthmatic patients Source: Eur Respir J 2003; 22: Suppl. 45, 88s Year: 2003